Tele: 561.316.3330
Breaking Medical Device News

Wednesday, September 22, 2021

HomeEXECUTIVESAlexander Margulis, PhD Appointed Senior Director of Azzur Labs Boston Team

Alexander Margulis, PhD Appointed Senior Director of Azzur Labs Boston Team

Alexander Margulis, PhD has been appointed senior director of Azzur Labs Boston.

Alexander Margulis, PhD brings to Azzur Labs more than 25 years of diverse experience in cellular and molecular biology, having worked for and alongside some of the nation’s leading pharmaceutical and biotech innovators. A subject matter expert in biotechnology and molecular biology, Alexander began his career specializing in the development and performance of cell-based assays, after which he transitioned to lab operations and business development roles serving the unique needs of Cambridge’s growing life science industry. Most recently, he served as the Chief Operating Officer of Mansfield Bio-Incubator, a not-for-profit organization specializing in assisting creation and growth for next-generation life sciences companies.

Alexander received his PhD in biochemistry and cell and molecular biology from the State University of New York at Stony Brook and his bachelor of science degree from Brandeis University.

“I’m thrilled to join Azzur Labs as the senior director of its Boston-area laboratory. This is indeed a remarkable time in history for our industry, and I look forward to leading Azzur Labs’ Boston team while embarking on new service offerings for our esteemed clients,” said Alexander.

Alexander joins Azzur Labs Boston as the firm relocates from Waltham, MA to a new, larger facility in Framingham. Azzur Labs’ comprehensive QC services are complemented by Azur Group Boston, a GxP consulting firm Azzur Cleanrooms OnDemand and Azzur Technical Services.

“Azzur Labs Boston is excited to welcome Alexander to our team. His unique and robust scientific and business development background affords him the opportunity to not only lead our team of scientists, but it also enables him to uncover unmet client needs and develop solutions to their challenges,” said Kym Faylor, President of Azzur Labs.

With full-scale operations in Pennsylvania, Raleigh, and Boston, Azzur Labs—an Azzur Group company—provides professional analytical compliance testing and consultative services for the pharmaceutical, biotechnology, and medical device industries. Azzur Group first opened its doors in Boston in 2013 with Azzur Group Boston, bringing comprehensive consultative services to the region, specializing in quality, validation, and compliance.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Kleiner Device Labs Receives FDA Market Clearance for KG2 Surge Flow-Thru Interbody System

The system maximizes total bone graft delivery volume, better distributes graft bilaterally into the intervertebral disc space, and streamlines the implant delivery, positioning, and grafting process for TLIF and PLIF spinal fusion procedures.

Matthew Cranfill New ExtriCARE USA Director Of Clinical Services

"Matt's impressive experience and skillset easily made him our top pick," said Peter Mason, President of ExtriCARE USA.

Shannon Lantzy MedCrypt New VP of Consulting

"I met Shannon at a healthcare-related event several years ago and was immediately impressed with her passion and drive to move healthcare into a digital future," said Mike Kijewski, CEO of MedCrypt.

Mark Foster Joins Xenocor BOD

Foster is a versatile and visionary C-Suite executive who brings 20 years of general management and leadership experience from both venture-backed growth-stage organizations and world-class medical device companies

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

By using this website you agree to accept Medical Device News Magazine Privacy Policy